AXA S.A. decreased its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 84.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,990 shares of the company's stock after selling 21,617 shares during the quarter. AXA S.A.'s holdings in Addus HomeCare were worth $500,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Natixis raised its stake in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after buying an additional 214 shares during the period. Parkside Financial Bank & Trust grew its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Addus HomeCare during the fourth quarter valued at about $86,000. 95.35% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of analysts recently issued reports on ADUS shares. Macquarie raised their price target on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Stephens reissued an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Oppenheimer upped their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of "Buy" and a consensus target price of $142.57.
View Our Latest Analysis on ADUS
Addus HomeCare Stock Performance
Shares of NASDAQ:ADUS traded up $1.82 during trading hours on Thursday, reaching $110.06. The stock had a trading volume of 40,800 shares, compared to its average volume of 164,518. The firm's 50 day moving average is $99.66 and its 200-day moving average is $114.07. The stock has a market capitalization of $2.02 billion, a price-to-earnings ratio of 25.16, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same period last year, the business posted $1.21 EPS. The company's revenue was up 20.3% on a year-over-year basis. Analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
